The multicatalytic proteinase (MCP) prosome or proteasome is a large multifunctional complex which is believed to play a major role in non-lysosomal pathways of intracellular protein degradation and has recently been implicated in antigen processing. In this study, affinity-putifed antibodies against rat liver MCP were used to investigate the localization of the proteinase both in rat liver and in growing human L132 cells in culture, using electron microscopic immunogold techniques. Quanatation of the MCP in &rent subcellular localizations by morphometric analysis of electron micrographs showed the proportion in the nucleus to be 17% for hepatocytes and 51% for L132 cells, demon-Supported in part by an Acciones Integndas award from the British Council, DGICYT (grant # PTR91-001) and the Medical Research Council.
Introduction
The multicatalytic proteinase (MCP) is a large (700 KD) multisubunit complex which is widely distributed in eukaryotic cells (for reviews see 21, 24). It can account for 0.6% of the soluble protein in animal cells (12) . The proteinase has been isolated from many different sources and some of its characteristic properties have been found to be similar for the different MCPs.
The MCP complex is composed of many different types of subunits, each of molecular mass 22-34 KD. The subunits are arranged in a hollow cylindrical structure giving a side-on view that looks like a stack of four rings (3). This structure appears to be very similar to that of a number of other 16-20s cylindrical particles, including prosomes, ribonucleoprotein particles implicated in the control of translation (10). Prosomes and 19s "cylinder particles" have been shown to crossreact with anti-MCP antibodies and also to possess the proteolytic activities of MCP (2.8). It is therefore accepted that these particles are the same and they are also referred to as proteasomes.
MCP can cleave peptide bonds on the carboxyl side of basic, hydrophobic, and acidic amino acid residues and there is evidence strating differences in the distribution of MCP in different cell types. In hepatocytes, 14% of the total MCP was found associated with the endoplasmic reticulum. The remainder was localized in the cytoplasmic matrix. ImmunofluoteScenQ studies with G132 cells also showed a reaction in nuclei and cytoplasm. The localization of MCP is consistent with its proposed multiple functions in protein turnover, in the production of peptides for antigen presentation, and in RNA processing. (J Histochem Cytochem 4&1165-1172, 1992) KEY WORDS: Multicatalytic proteinase; Protcasomc; Protein turnover; Rat liver; Cultured cells; Colloidal gold; Immunoelectron microscopy; Antigen processing.
to suggest that these proteolytic activities are catalyzed by distinct active sites (21,24). The proteinase has been implicated in both ubiquitin-independent and ubiquitin-dependent pathways of intracellular protein breakdown (for reviews see 7, 23).
Knowledge of the intracellular distribution of MCP in ddferent cell types will help to elucidate its physiological role(s). There are reports of immunohistochemical localization in a variety of tissues including rat brain and muscle (IS), human liver (28), Drosophila (U), sea urchin (I), and newt ( 2 4 , where MCP was observed in both the nucleus and cytoplasm. However, there are discrepancies in the literature with regard to the relative distribution of MCP, and in some cases no staining of nuclei has been observed (1,11,15,22,28). In this article we report a more detailed study of previously communicated (18) investigations of the localization of the MCP complex in rat liver and in growing human L-132 cells, as determined by immunoelectron microscopy using polyclonal antibodies raised against the purified rat liver MCP. The results clearly demonstrate the presence of MCP in the nucleus and the cytoplasm, with some antibody associated with the endoplasmic reticulum and around the nucleolus. The proportion of antibody in each location can vary in different cells.
Materials and Methods
Chemicals. Triton X-100. sodium deoxycholate, sodium dodecyl sulfate, sodium azide, EDTA, leupeptin, pepstatin, phenylmethyl sulfonyl fluo-
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RIVETT, PALMER, KNECHT ride. porcine pancreatic trypsin, aprotinin. anti-rabbit IgG-fluorescein isothiocyanatc-conjugated F(ab)z fragment (ref. F1262). sucrose. and uranyl acetate were from Sigma (St Louis, MO). HAuC4, trisodium citrate. and lead nitrate were from Merck (Darmstadt. Germany). Protein A was from Pharmacia Fine Chemicals (Uppsala, Sweden). Glutaraldehyde and formaldehyde were from Tousimis (Rockville. MD). Acrylamide was from Bio-Rad (Richmond, CA). Lowicryl K4M and LR Gold were from Polysciences (Warrington, PA). Cell culture media and sera were from Flow Laboratories (Irvine, Scotland, UK). Other reagents were of analytical quality.
Animals. Immunocytochemical localization experiments were carried out on the livers of fed male Wistar rats (250 g). New Zealand White rabbits, weighing 2-3 kg. were used for immunizations. General Methods. MCP was purified from rat liver, modified with dinitrobenzene sulfonic acid, and used to raise polyclonal antibodies as described previously (25) . Positive antisera were identified by enzyme-linked immunosorbent assay (ELISA) (6) . IgG preparations (25) were used to produce affinity-purified antibodies, which are referred to here as anti-MCP antibodies. Their specificity was checked by the Western blot transfer technique (29) using rat liver extracts prepared as described previously (25) . Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out in 15% polyacrylamide slab gels (20) . L132 cell extracts were prepared by homogenization in ice-cold 1% Triton X-100, 0.5% sodium deoxycholate. 0.1% sodium dodecyl sulfate. 0.01% sodium azide, 0.1 M NaCI, 5 mM EDTA. 1 mM leupeptin. 2 mM phenylmethyl sulfonyl fluoride, 1 @ml aprotinin. 1 mM pepstatin, 10 mM phosphate buffer, pH 7.5. A modified Lowry procedure (4) was used to measure protein. Monoclonal antibodies to glutamate dehydrogenase were prepared and assayed as described elsewhere (17) . Dot-blotting was carried out by applying 1 pI droplets of purified MCP (1 mg/ml) to nitrocellulose paper (ref. 162-0116; Bio-Rad) disks of 6 mm diameter. After drying, the disks were treated with the immunological reagents as described for tissue specimens, and occasionally the labeling was enhanced with silver lactate (14) .
Preparation of Sample for Immunocytochemistry. Rats were anesthetized with ether, decapitated. and the liver was removed and processed immediately. L132 cells were detached from the flasks with 0.25% trypsin in PBS (pH 7.4) and sedimented at 1500 x g for 10 min. Small fragments from liver or sediments from the cultured cells were fixed in a mixture of 1% glutaraldehyde and 0.7% formaldehyde. buffered with 0.1 M cacodylate (pH 7.2) at 4'C for 90 min. and washed overnight in 0.1 M cacodylate buffer containing 5% sucrose. Dehydration and embedding at low temperature (-35'C) in Lowicryl K4M and LR Gold were carried out according to the manufacturer's instructions (17) .
Immunocytochemical proacdurrs. The protein A-gold (pAg) technique (26) was used to localize MCP. Colloidal gold suspensions were prepared from HAuC4. using trisodium citrate. as previously described in detail (17) . These suspensions were adjusted to pH 5.5 to label protein A (17) . Before use, the protein A-gold complexes were separated from free protein A by centrifugation for 5 min at 15 psi (79,000 x g) in a Beckman Airfuge (ro-line lead citrate. In some experiments, the staining with lead citrate was omitted to facilitate identification of the gold particles. The following control incubations were carried out: (a) incubation with non-immune rabbit IgG instead of the polyclonal antibodies; (b) incubation with immunogold alone; and (c) pre-adsorption of the anti-MCP IgG with an excess of MCP for 2 hr at 2O'C with agitation for 30 sec in a vortex at 30-min intervals, before performing the immunogold procedure. All gave similar results (0.6 2 0.2 gold particleslpn'). As a final check of the specificity of the protein A-gold conjugates, the mitochondrial enzyme glutamate dehydrogenase was localized with monoclonal antibodies and the same protein A-gold conjugates used in the localization of MCP.
For immunofluorescent labeling, cells growing on glass disks were cooled on ice. washed twice in cold PBS. fixed for I5 min at 4°C in ethano1:acetone (1:l. v:v). incubated with anti-MCP for 2 hr at 4°C. washed four times in cold PBS ( 5 min each). incubated for 1 hr at 4'C in the dark with antirabbit IgG-fluorescein isothiocyanate-conjugated F(ab)2 fragment diluted 1:30 in PBS, washed four times with PBS, and obscrvcd immediately.
Morphometric analysis was performed by the point-counting method, using multipurpose test systems prepared as described previously (30). For each sample. 20-30 different and randomly selected (areas located in the upper right corner of the supporting nickel grids) electron micrographs (at a final standard magnification of x 20,000) from three different grids (representing three different rats or cell cultures) were analyzed. This represents more than 2000 pm' cell area for each cell type. Optimal point density for each cell compartment was determined as described (30). Gold labeling densities are expressed as number of gold particles/p~' of each cell compartment. All results are means 2 standard deviation ofthree different samples. incubated simultaneously and using the same antibodies and the same immunogold conjugates. These precautions should minimize variations due to different proportions of unconjugated protein A, to different gold sizes, or to different antibody preparations. Statistical analysis was performed by the Student's t-test. 
Results
In SDS-PAGE gels, MCP appears to be composed of many nonidentical subunits of Mr 22.000-34,000 (Figure 1. Lane 2) . The affinity-purified anti-MCP, at the dilution used in the electron microscopic experiments, reacted in Western blot analysis with most of the components of purified rat liver MCP (Figure 1, Lane 3) . These antibodies also crossreacted specifically with several polypeptides with sites in the range of 22-34 KD, out of a large number of proteins from extracts of rat liver (Figure 1, Lane 4) or human L-132 cells (Figure 1, Lane 5 ) .
A two-step immunocytochemical procedure is more sensitive than a single-step procedure. Therefore, we used the protein A-gold technique (26) to localize MCP in rat liver and L132 cells. Protein A-gold combined with the MCP antibodies recognized MCP in a dot-blot immunosorbent assay (not shown). After applying anti-MCP followed by protein A-gold complex (gold size c. 17 nm), to rat liver sections, labeling by gold particles was seen in cytoplasm and nuclei of hepatocytes (Figures 2a and 2b ) and sinusoidal cells (not shown). The same results were obtained regardless of whether Lowicryl K4M or LR Gold embedding was used. In nuclei, labeling was distributed in the nuclear matrix but mainly in the periphery of heterochromatin and of nucleoli (Figure 2c ). In cytoplasm, gold particles were found diffusely in the ground substance and sometimes close to or actually on the rough endoplasmic reticulum, but usually outside the endoplasmic cisternae ( Figure 2d ) and in polysomes. Labeling was practically nonexistent within mitochon- dria, peroxisomes, and components of the vacuolar system, and in the embedding matrix (i.e., reaction was confined to specific areas in the cells).
Control incubations with non-immune serum, treated in the same way as the affinity-purified antibody (Figure 3a) . with protein A-gold alone, or with the antibodies pre-incubated with an excess of MCP before performing the immunogold procedure provided evidence of the specificity of labeling. As a control for methodology, the mitochondrial enzyme glutamate dehydrogenase was localized in parallel experiments to those performed with anti-MCP. Labeling was restricted to mitochondria (Figure 3b) .
The labeling obtained with anti-MCP in L132 cells was similar to that found in hepatocytes: again, gold particles were seen on both the cytoplasm and the nuclear matrices (Figure 4) . Control incubations similar to those performed with rat liver gave equally negative results. The localization of MCP in the nucleus and cytoplasm of L-132 cells using the affinity-purified antibodies towards MCP was also confirmed by immunofluorescence (Figure 5 ) .
The density of labeling with anti-MCP and protein A-gold in different compartments of hepatocytes and L132 cells is shown in Tables 1 and 2, respectively. Only the nuclear and cytoplasmic matrices and the endoplasmic reticulum and nucleolar areas (which included the associated heterochromatin) showed a signifcant labeling (compared with control values). 
Discussion
Antibodies raised against the rat liver MCP crossreact not only with MCP from other tissues of the rat (25) but also with MCP from a variety of mammalian sources when tested by immunoblotting and immunoprecipitation. They are therefore suitable for localization studies that use cultured human cells. MCP was found in the nucleus as well as the cytoplasm of both rat liver and growing human cells, consistent with results of immunohistochemical studies with human liver and rat brain and muscle (15, 28) . Since we started this work, the purification of rat liver MCP from isolated nuclear and cytoplasmic fractions has also been reported (28) and the two MCP preparations found to have similar properties.
Comparison of the distribution of MCP in rat liver and L132 cells determined by immunogold electron microscopy demonstrates that there are differences in localization in different cell types. Labeling of nuclei was more predominant in actively growing L132 cells than in hepatocytes, although this can be explained in part by the larger relative size of the nuclei of L132 cells. Such differences may explain apparent discrepancies in the literature with regard to the proportion of MCP in the nucleus and cytoplasm. In some cases the complex has been located largely in the cytoplasm, whereas in other cases it appears to be predominantly in nuclei. For example, MCP is predominantly nuclear in growing rat fibroblasts (2), in human leukocytic cells (19) , and in muscle cells (27), but is apparently absent from the nucleus of some human liver cells (28). Changes in localization have been observed during development of lower eukaryotes including Drosophila (11) , sea urchin (I), and newt (22) .
The identification in rat liver of 14% of the label close to or on the endoplasmic reticulum is consistent with suggestions that MCP may be the cytoplasmic proteinase that generates peptides for transport through the endoplasmic reticulum for presentation in association with the major histocompatibility complex Class I molecules (5 $) .
In addition, the localization of gold label in euchromatin and at the periphery of heterochromatin, nucleoli, rough endoplasmic reticulum, and polyribosomes suggests a role in RNA processing, ribo- some assembly, and translation ofmRNA (13). Cytoplasmic 19s ringtype particles (proteasomes) from Drosopbih exist either free or in tight association with polyribosomes (16) . In addition, Scherrer and co-workers (10) have reported an association of prosomes with intermediate filaments of the cytokeratin type. These particles have been found to be associated with repressed mRNA and have been suggested to play a role in controlling translation (10, 22) . Although our results confirm that the localization of MCP is consistent with proposed functions in RNA processing, further studies are required to establish its precise role(s). The involvement of the MCP complex in protein turnover is now well accepted (21, 23) , and it has recently been implicated in antigen processing (5, 9) . Differences in the localization of MCP in different cell types may reflect multiple functions of the complex, the relative importance of which could vary in different cells.
